Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. De Fijter, JW; Mallat, MJK; Doxiadis, IIN; Ringers, J; Rosendaal, FR; Claas, FHJ; Paul, LC
   Increased immunogenicity and cause of graft loss of old donor kidneys
   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
   
   J.W. De Fijter et al., "Increased immunogenicity and cause of graft loss of old donor kidneys", J AM S NEPH, 12(7), 2001, pp. 1538-1546
2. Vandenbroucke, JP; van der Meer, FJM; Helmerhorst, FM; Rosendaal, FR
   Family history and risk of venous thromboembolism with oral contraception - Family history is important tool
   BRITISH MEDICAL JOURNAL
   
   J.P. Vandenbroucke et al., "Family history and risk of venous thromboembolism with oral contraception - Family history is important tool", BR MED J, 323(7315), 2001, pp. 752-752
3. Couture, P; Bovill, EG; Demers, C; Simard, J; Delage, R; Scott, BT; Valliere, JE; Callas, PW; Jomphe, M; Rosendaal, FR; Aiach, M; Long, GL
   Evidence of a founder effect for the protein C gene 3363 inserted C mutation in thrombophilic pedigrees of French origin
   THROMBOSIS AND HAEMOSTASIS
   
   P. Couture et al., "Evidence of a founder effect for the protein C gene 3363 inserted C mutation in thrombophilic pedigrees of French origin", THROMB HAEM, 86(4), 2001, pp. 1000-1006
4. Emmerich, J; Rosendaal, FR; Cattaneo, M; Margaglione, M; De Stefano, V; Cumming, T; Arruda, V; Hillarp, A; Reny, JL
   Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including2310 cases and 3204 controls
   THROMBOSIS AND HAEMOSTASIS
   
   J. Emmerich et al., "Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism - Pooled analysis of 8 case-control studies including2310 cases and 3204 controls", THROMB HAEM, 86(3), 2001, pp. 809-816
5. Penning-van Beest, FJA; van Meegen, E; Rosendaal, FR; Stricker, BHC
   Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation
   THROMBOSIS AND HAEMOSTASIS
   
   F.J.A. Penning-van Beest et al., "Characteristics of anticoagulant therapy and comorbidity related to overanticoagulation", THROMB HAEM, 86(2), 2001, pp. 569-574
6. Rosendaal, FR; Helmerhorst, FM; Vandenbroucke, JP
   Oral contraceptives, hormone replacement therapy and thrombosis
   THROMBOSIS AND HAEMOSTASIS
   
   F.R. Rosendaal et al., "Oral contraceptives, hormone replacement therapy and thrombosis", THROMB HAEM, 86(1), 2001, pp. 112-123
7. de Visser, MCH; Poort, SR; Vos, HL; Rosendaal, FR; Bertina, RM
   Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis
   THROMBOSIS AND HAEMOSTASIS
   
   M.C.H. de Visser et al., "Factor X levels, polymorphisms in the promoter region of factor X, and therisk of venous thrombosis", THROMB HAEM, 85(6), 2001, pp. 1011-1017
8. Ceelie, H; Bertina, RM; Vlieg, AV; Rosendaal, FR; Vos, HL
   Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels
   THROMBOSIS AND HAEMOSTASIS
   
   H. Ceelie et al., "Polymorphisms in the prothrombin gene and their association with plasma prothrombin levels", THROMB HAEM, 85(6), 2001, pp. 1066-1070
9. Reiner, AP; Siscovick, DS; Rosendaal, FR
   Hemostatic risk factors and arterial thrombotic disease
   THROMBOSIS AND HAEMOSTASIS
   
   A.P. Reiner et al., "Hemostatic risk factors and arterial thrombotic disease", THROMB HAEM, 85(4), 2001, pp. 584-595
10. Wesseling, J; Van Driel, D; Heymans, HSA; Rosendaal, FR; Geven-Boere, LM; Smrkovsky, M; Touwen, BCL; Sauer, PJJ; Van der Veer, E
    Coumarins during pregnancy: Long-term effects on growth and development ofschool-age children
    THROMBOSIS AND HAEMOSTASIS
    
    J. Wesseling et al., "Coumarins during pregnancy: Long-term effects on growth and development ofschool-age children", THROMB HAEM, 85(4), 2001, pp. 609-613
11. Psaty, BM; Smith, NL; Lemaitre, RN; Vos, HL; Heckbert, SR; LaCroix, AZ; Rosendaal, FR
    Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    B.M. Psaty et al., "Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women", J AM MED A, 285(7), 2001, pp. 906-913
12. Reiner, AP; Schwartz, SM; Frank, MB; Longstreth, WT; Hindorff, LA; Teramura, G; Rosendaal, FR; Gaur, LK; Psaty, BM; Siscovick, DS
    Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women
    STROKE
    
    A.P. Reiner et al., "Polymorphisms of coagulation factor XIII subunit A and risk of nonfatal hemorrhagic stroke in young white women", STROKE, 32(11), 2001, pp. 2580-2585
13. Vandenbroucke, JP; Rosing, J; Bloemenkamp, KWM; Middeldorp, S; Helmerhorst, FM; Bouma, BN; Rosendaal, FR
    Oral contraceptives and the risk of venous thrombosis.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    J.P. Vandenbroucke et al., "Oral contraceptives and the risk of venous thrombosis.", N ENG J MED, 344(20), 2001, pp. 1527-1535
14. Torn, M; Algra, A; Rosendaal, FR
    Oral anticoagulation for cerebral ischemia of arterial origin - High initial bleeding risk
    NEUROLOGY
    
    M. Torn et al., "Oral anticoagulation for cerebral ischemia of arterial origin - High initial bleeding risk", NEUROLOGY, 57(11), 2001, pp. 1993-1999
15. Friedlander, Y; Arbogast, P; Schwartz, SM; Marcovina, SM; Austin, MA; Rosendaal, FR; Reiner, AP; Psaty, BM; Siscovick, DS
    Family history as a risk factor for early onset myocardial infarction in young women
    ATHEROSCLEROSIS
    
    Y. Friedlander et al., "Family history as a risk factor for early onset myocardial infarction in young women", ATHEROSCLER, 156(1), 2001, pp. 201-207
16. Janssen, HLA; Wijnhoud, A; Haagsma, EB; van Uum, SHM; van Nieuwkerk, CMJ; Adang, RP; Chamuleau, RAFM; van Hattum, J; Vleggaar, FP; Hansen, BE; Rosendaal, FR; van Hoek, B
    Extrahepatic portal vein thrombosis: aetiology and determinants of survival
    GUT
    
    H.L.A. Janssen et al., "Extrahepatic portal vein thrombosis: aetiology and determinants of survival", GUT, 49(5), 2001, pp. 720-724
17. Penning-van Beest, FJA; van Meegen, E; Rosendaal, FR; Stricker, BH
    Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs
    CLINICAL PHARMACOLOGY & THERAPEUTICS
    
    F.J.A. Penning-van Beest et al., "Drug interactions as a cause of overanticoagulation on phenprocoumon or acenocoumarol predominantly concern antibacterial drugs", CLIN PHARM, 69(6), 2001, pp. 451-457
18. Sramek, A; Reiber, JHC; Gerrits, WBJ; Rosendaal, FR
    Decreased coagulability has no clinically relevant effect on atherogenesis- Observations in individuals with a hereditary bleeding tendency
    CIRCULATION
    
    A. Sramek et al., "Decreased coagulability has no clinically relevant effect on atherogenesis- Observations in individuals with a hereditary bleeding tendency", CIRCULATION, 104(7), 2001, pp. 762-767
19. Thomassen, R; Vandenbroucke, JP; Rosendaal, FR
    Antipsychotic medication and venous thrombosis
    BRITISH JOURNAL OF PSYCHIATRY
    
    R. Thomassen et al., "Antipsychotic medication and venous thrombosis", BR J PSYCHI, 179, 2001, pp. 63-66
20. Kamphuisen, PW; Eikenboom, JCJ; Rosendaal, FR; Koster, T; Blann, AD; Vos, HL; Bertina, RM
    High factor VIII antigen levels increase the risk of venous thrombosis butare not associated with polymorphisms in the von Willebrand factor and factor VIII gene
    BRITISH JOURNAL OF HAEMATOLOGY
    
    P.W. Kamphuisen et al., "High factor VIII antigen levels increase the risk of venous thrombosis butare not associated with polymorphisms in the von Willebrand factor and factor VIII gene", BR J HAEM, 115(1), 2001, pp. 156-158
21. Lensen, R; Bertina, RM; Vandenbroucke, JP; Rosendaal, FR
    High factor VIII levels contribute to the thrombotic risk in families withfactor V Leiden
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R. Lensen et al., "High factor VIII levels contribute to the thrombotic risk in families withfactor V Leiden", BR J HAEM, 114(2), 2001, pp. 380-386
22. Reiner, AP; Schwartz, SM; Kumar, PN; Rosendaal, FR; Pearce, RM; Aramaki, KM; Psaty, BM; Siscovick, DS
    Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women
    BRITISH JOURNAL OF HAEMATOLOGY
    
    A.P. Reiner et al., "Platelet glycoprotein IIb polymorphism, traditional risk factors and non-fatal myocardial infarction in young women", BR J HAEM, 112(3), 2001, pp. 632-636
23. Frank, MB; Reiner, AP; Schwartz, SM; Kumar, PN; Pearce, RM; Arbogast, PG; Longstreth, WT; Rosendaal, FR; Psaty, BM; Siscovick, DS
    The Kozak sequence polymorphism of platelet glycoprotein Ib alpha and riskof nonfatal myocardial infarction and nonfatal stroke in young women
    BLOOD
    
    M.B. Frank et al., "The Kozak sequence polymorphism of platelet glycoprotein Ib alpha and riskof nonfatal myocardial infarction and nonfatal stroke in young women", BLOOD, 97(4), 2001, pp. 875-879
24. Janssen, HLA; Rosendaal, FR
    Acquired and inherited risk factors for Budd-Chiari syndrome and portal vein thrombosis - Response
    BLOOD
    
    H.L.A. Janssen e F.R. Rosendaal, "Acquired and inherited risk factors for Budd-Chiari syndrome and portal vein thrombosis - Response", BLOOD, 97(10), 2001, pp. 3315-3315
25. Bloemenkamp, KWM; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP
    Lack of objectivity in the debate concerning third-generation oral contraceptives and venous thrombosis - In reply
    ARCHIVES OF INTERNAL MEDICINE
    
    K.W.M. Bloemenkamp et al., "Lack of objectivity in the debate concerning third-generation oral contraceptives and venous thrombosis - In reply", ARCH IN MED, 161(3), 2001, pp. 484-485
26. Kamphuisen, PW; Rosendaal, FR; Eikenboom, JCJ; Bos, R; Bertina, RM
    Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    P.W. Kamphuisen et al., "Factor V antigen levels and venous thrombosis - Risk profile, interaction with factor V Leiden, and relation with factor VIII antigen levels", ART THROM V, 20(5), 2000, pp. 1382-1386
27. Vandenbroucke, JP; Helmerhorst, FM; Rosendaal, FR
    Competing interests and controversy about third generation oral contraceptives - BMJ readers should know whose words they read
    BRITISH MEDICAL JOURNAL
    
    J.P. Vandenbroucke et al., "Competing interests and controversy about third generation oral contraceptives - BMJ readers should know whose words they read", BR MED J, 320(7231), 2000, pp. 381-382
28. Vandenbroucke, JP; Bloemenkamp, KWM; Rosendaal, FR; Helmerhorst, FM
    Incidence of venous thromboembolism in users of combined oral contraceptives - Risk is particularly high with first use of oral contraceptives
    BRITISH MEDICAL JOURNAL
    
    J.P. Vandenbroucke et al., "Incidence of venous thromboembolism in users of combined oral contraceptives - Risk is particularly high with first use of oral contraceptives", BR MED J, 320(7226), 2000, pp. 57-57
29. Doggen, CJM; Berckmans, RJ; Sturk, A; Cats, VM; Rosendaal, FR
    C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men
    JOURNAL OF INTERNAL MEDICINE
    
    C.J.M. Doggen et al., "C-reactive protein, cardiovascular risk factors and the association with myocardial infarction in men", J INTERN M, 248(5), 2000, pp. 406-414
30. Psaty, BM; Doggen, C; Vos, HL; Vandenbroucke, JP; Rosendaal, FR
    Association of the alpha-adducin polymorphism with blood pressure and riskof myocardial infarction
    JOURNAL OF HUMAN HYPERTENSION
    
    B.M. Psaty et al., "Association of the alpha-adducin polymorphism with blood pressure and riskof myocardial infarction", J HUM HYPER, 14(2), 2000, pp. 95-97
31. Weijl, NI; Rutten, MFJ; Zwinderman, AH; Keizer, HJ; Nooy, MA; Rosendaal, FR; Cleton, FJ; Osanto, S
    Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature
    JOURNAL OF CLINICAL ONCOLOGY
    
    N.I. Weijl et al., "Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature", J CL ONCOL, 18(10), 2000, pp. 2169-2178
32. Doggen, CJM; de Visser, MCH; Vos, HL; Bertina, RM; Cats, VM; Rosendaal, FR
    The HR2 haplotype of factor V is not associated with the risk of myocardial infarction
    THROMBOSIS AND HAEMOSTASIS
    
    C.J.M. Doggen et al., "The HR2 haplotype of factor V is not associated with the risk of myocardial infarction", THROMB HAEM, 84(5), 2000, pp. 815-818
33. Lensen, RPM; Bertina, RM; de Ronde, H; Vandenbroucke, JP; Rosendaal, FR
    Venous thrombotic risk in family members of unselected individuals with factor V Leiden
    THROMBOSIS AND HAEMOSTASIS
    
    R.P.M. Lensen et al., "Venous thrombotic risk in family members of unselected individuals with factor V Leiden", THROMB HAEM, 83(6), 2000, pp. 817-821
34. de Visser, MCH; Guasch, JF; Kamphuisen, PW; Vos, HL; Rosendaal, FR; Bertina, RM
    The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    M.C.H. de Visser et al., "The HR2 haplotype of factor V: Effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis", THROMB HAEM, 83(4), 2000, pp. 577-582
35. Eekhoff, EMW; Rosendaal, FR; Vandenbroucke, JP
    Minor events and the risk of deep venous thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    E.M.W. Eekhoff et al., "Minor events and the risk of deep venous thrombosis", THROMB HAEM, 83(3), 2000, pp. 408-411
36. Rosendaal, FR
    High levels of factor VIII and venous thrombosis
    THROMBOSIS AND HAEMOSTASIS
    
    F.R. Rosendaal, "High levels of factor VIII and venous thrombosis", THROMB HAEM, 83(1), 2000, pp. 1-2
37. Van Driel, D; Wesseling, J; Rosendaal, FR; Odink, RJ; Van der Veer, E; Gerver, WJ; Geven-Boere, LM; Sauer, PJJ
    Growth until puberty after in utero exposure to coumarins
    AMERICAN JOURNAL OF MEDICAL GENETICS
    
    D. Van Driel et al., "Growth until puberty after in utero exposure to coumarins", AM J MED G, 95(5), 2000, pp. 438-443
38. Thomassen, R; Vandenbroucke, JP; Rosendaal, FR
    Antipsychotic drugs and venous thromboembolism
    LANCET
    
    R. Thomassen et al., "Antipsychotic drugs and venous thromboembolism", LANCET, 356(9225), 2000, pp. 252-252
39. Reiner, AP; Kumar, PN; Schwartz, SM; Longstreth, WT; Pearce, RM; Rosendaal, FR; Psaty, BM; Siscovick, DS
    Genetic variants of platelet glycoprotein receptors and risk of stroke in young women
    STROKE
    
    A.P. Reiner et al., "Genetic variants of platelet glycoprotein receptors and risk of stroke in young women", STROKE, 31(7), 2000, pp. 1628-1633
40. Meijers, JCM; Rosendaal, FR
    Coagulation factor XI and venous thrombosis - Reply
    NEW ENGLAND JOURNAL OF MEDICINE
    
    J.C.M. Meijers e F.R. Rosendaal, "Coagulation factor XI and venous thrombosis - Reply", N ENG J MED, 343(3), 2000, pp. 221-221
41. Meijers, JCM; Tekelenburg, WLH; Bouma, BN; Bertina, RM; Rosendaal, FR
    High levels of coagulation factor XI as a risk factor for venous thrombosis.
    NEW ENGLAND JOURNAL OF MEDICINE
    
    J.C.M. Meijers et al., "High levels of coagulation factor XI as a risk factor for venous thrombosis.", N ENG J MED, 342(10), 2000, pp. 696-701
42. Sramek, A; Bosch, JG; Reiber, JHC; Van Oostayen, JA; Rosendaal, FR
    Ultrasound assessment of atherosclerotic vessel wall changes - Reproducibility of intima-media thickness measurements in carotid and femoral arteries
    INVESTIGATIVE RADIOLOGY
    
    A. Sramek et al., "Ultrasound assessment of atherosclerotic vessel wall changes - Reproducibility of intima-media thickness measurements in carotid and femoral arteries", INV RADIOL, 35(12), 2000, pp. 699-706
43. Doggen, CJM; Bertina, RM; Cats, VM; Rosendaal, FR
    Fibrinogen polymorphisms are not associated with the risk of myocardial infarction
    BRITISH JOURNAL OF HAEMATOLOGY
    
    C.J.M. Doggen et al., "Fibrinogen polymorphisms are not associated with the risk of myocardial infarction", BR J HAEM, 110(4), 2000, pp. 935-938
44. Kamphuisen, PW; Lensen, R; Houwing-Duistermaat, JJ; Eikenboom, JCJ; Harvey, M; Bertina, RM; Rosendaal, FR
    Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    P.W. Kamphuisen et al., "Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia", BR J HAEM, 109(3), 2000, pp. 519-522
45. Blann, AD; Noteboom, WMP; Rosendaal, FR
    Increased soluble P-selectin levels following deep venous thrombosis: cause or effect
    BRITISH JOURNAL OF HAEMATOLOGY
    
    A.D. Blann et al., "Increased soluble P-selectin levels following deep venous thrombosis: cause or effect", BR J HAEM, 108(1), 2000, pp. 191-193
46. Janssen, HLA; Meinardi, JR; Vleggaar, FP; van Uum, SHM; Haagsma, EB; van der Meer, FJM; van Hattum, J; Chamuleau, RAFM; Adang, RP; Vandenbroucke, JP; van Hoek, B; Rosendaal, FR
    Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study
    BLOOD
    
    H.L.A. Janssen et al., "Factor V Leiden mutation, prothrombin gene mutation, and deficiencies in coagulation inhibitors associated with Budd-Chiari syndrome and portal vein thrombosis: results of a case-control study", BLOOD, 96(7), 2000, pp. 2364-2368
47. van Tilburg, NH; Rosendaal, FR; Bertina, RM
    Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis
    BLOOD
    
    N.H. van Tilburg et al., "Thrombin activatable fibrinolysis inhibitor and the risk for deep vein thrombosis", BLOOD, 95(9), 2000, pp. 2855-2859
48. Vlieg, AV; van der Linden, IK; Bertina, RM; Rosendaal, FR
    High levels of factor IX increase the risk of venous thrombosis
    BLOOD
    
    A.V. Vlieg et al., "High levels of factor IX increase the risk of venous thrombosis", BLOOD, 95(12), 2000, pp. 3678-3682
49. Zidane, M; Schram, MT; Planken, EW; Molendijk, WH; Rosendaal, FR; van der Meer, FJM; Huisman, MV
    Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism - A study in routine clinical practice
    ARCHIVES OF INTERNAL MEDICINE
    
    M. Zidane et al., "Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism - A study in routine clinical practice", ARCH IN MED, 160(15), 2000, pp. 2369-2373
50. Kaplan, RC; Heckbert, SR; Koepsell, TD; Rosendaal, FR; Psaty, BM
    Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding
    ARCHIVES OF INTERNAL MEDICINE
    
    R.C. Kaplan et al., "Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding", ARCH IN MED, 160(12), 2000, pp. 1849-1855
51. Bloemenkamp, KWM; Rosendaal, FR; Helmerhorst, FM; Vandenbroucke, JP
    Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects
    ARCHIVES OF INTERNAL MEDICINE
    
    K.W.M. Bloemenkamp et al., "Higher risk of venous thrombosis during early use of oral contraceptives in women with inherited clotting defects", ARCH IN MED, 160(1), 2000, pp. 49-52
52. Rattink, AP; Hennis, BC; Lievers, CJA; de Maat, MPM; Bertina, R; Mennen, LI; Rosendaal, FR
    Deep vein thrombosis is not associated with the P/S186 polymorphism of histidine rich glycoprotein
    FIBRINOLYSIS & PROTEOLYSIS
    
    A.P. Rattink et al., "Deep vein thrombosis is not associated with the P/S186 polymorphism of histidine rich glycoprotein", FIBRINOL PR, 13(1), 1999, pp. 35-38
53. Bucciarelli, P; Rosendaal, FR; Tripodi, A; Mannucci, PM; De Stefano, V; Palareti, G; Finazzi, G; Baudo, F; Quintavalla, R
    Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    P. Bucciarelli et al., "Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study", ART THROM V, 19(4), 1999, pp. 1026-1033
54. Hille, ETM; Siesling, S; Vegter-van der Vlis, M; Vandenbroucke, JP; Roos, RAC; Rosendaal, FR
    Two centuries of mortality in ten large families with Huntington disease: A rising impact of gene carriership
    EPIDEMIOLOGY
    
    E.T.M. Hille et al., "Two centuries of mortality in ten large families with Huntington disease: A rising impact of gene carriership", EPIDEMIOLOG, 10(6), 1999, pp. 706-710
55. Cannegieter, SC; Torn, M; Rosendaal, FR
    Oral anticoagulant treatment in patients with mechanical heart valves: howto reduce the risk of thromboembolic and bleeding complications
    JOURNAL OF INTERNAL MEDICINE
    
    S.C. Cannegieter et al., "Oral anticoagulant treatment in patients with mechanical heart valves: howto reduce the risk of thromboembolic and bleeding complications", J INTERN M, 245(4), 1999, pp. 369-374
56. Bloemenkamp, KWM; Helmerhorst, FM; Rosendaal, FR; Vandenbroucke, JP
    Venous thrombosis, oral contraceptives and high factor VIII levels
    THROMBOSIS AND HAEMOSTASIS
    
    K.W.M. Bloemenkamp et al., "Venous thrombosis, oral contraceptives and high factor VIII levels", THROMB HAEM, 82(3), 1999, pp. 1024-1027
57. Liberti, G; Bertina, RM; Rosendaal, FR
    Hormonal state rather than age influences cut-off values of protein S: Reevaluation of the thrombotic risk associated with protein S deficiency
    THROMBOSIS AND HAEMOSTASIS
    
    G. Liberti et al., "Hormonal state rather than age influences cut-off values of protein S: Reevaluation of the thrombotic risk associated with protein S deficiency", THROMB HAEM, 82(3), 1999, pp. 1093-1096
58. Rosendaal, FR
    Risk factors for venous thrombotic disease
    THROMBOSIS AND HAEMOSTASIS
    
    F.R. Rosendaal, "Risk factors for venous thrombotic disease", THROMB HAEM, 82(2), 1999, pp. 610-619
59. Doggen, CJM; Bertina, RM; Cats, VM; Reitsma, PH; Rosendaal, FR
    The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction
    THROMBOSIS AND HAEMOSTASIS
    
    C.J.M. Doggen et al., "The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction", THROMB HAEM, 82(1), 1999, pp. 115-120
60. Kamphuisen, PW; Eikenboom, JCJ; Vos, HL; Pablo, R; Sturk, A; Bertina, RM; Rosendaal, FR
    Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions
    THROMBOSIS AND HAEMOSTASIS
    
    P.W. Kamphuisen et al., "Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions", THROMB HAEM, 81(5), 1999, pp. 680-683
61. van der Meer, FJM; Vos, HL; Rosendaal, FR
    No indication for APTT screening in patients on oral anticoagulant therapy
    THROMBOSIS AND HAEMOSTASIS
    
    F.J.M. van der Meer et al., "No indication for APTT screening in patients on oral anticoagulant therapy", THROMB HAEM, 81(3), 1999, pp. 364-366
62. Rosendaal, FR
    Venous thrombosis: Prevalence and interaction of risk factors
    HAEMOSTASIS
    
    F.R. Rosendaal, "Venous thrombosis: Prevalence and interaction of risk factors", HAEMOSTASIS, 29, 1999, pp. 1-9
63. Bloemenkamp, KW; Rosendaal, FR; Helmerhorst, FM; Vandenbroucke, JP
    Venous thromboembolism and oral contraceptives
    LANCET
    
    K.W. Bloemenkamp et al., "Venous thromboembolism and oral contraceptives", LANCET, 354(9188), 1999, pp. 1469-1469
64. Psaty, BM; Weiss, NS; Furberg, CD; Koepsell, TD; Siscovick, DS; Rosendaal, FR; Smith, NL; Heckbert, SR; Kaplan, RC; Lin, DY; Fleming, TR; Wagner, EH
    Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    
    B.M. Psaty et al., "Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease", J AM MED A, 282(8), 1999, pp. 786-790
65. Doggen, CJM; Rosendaal, FR; Cats, VM; Bertina, RM
    Factor V leiden, prothrombin 20210 gene variant, and risk of myocardial infarction - Reply
    CIRCULATION
    
    C.J.M. Doggen et al., "Factor V leiden, prothrombin 20210 gene variant, and risk of myocardial infarction - Reply", CIRCULATION, 99(3), 1999, pp. 457-458
66. Penning-van Beest, FJA; Rosendaal, FR; Grobbee, DE; van Meegen, E; Stricker, BHC
    Course of the International Normalized Ratio in response to oral vitamin K-1 in patients overanticoagulated with phenprocoumon
    BRITISH JOURNAL OF HAEMATOLOGY
    
    F.J.A. Penning-van Beest et al., "Course of the International Normalized Ratio in response to oral vitamin K-1 in patients overanticoagulated with phenprocoumon", BR J HAEM, 104(2), 1999, pp. 241-245
67. van Boven, HH; Vandenbroucke, JP; Briet, E; Rosendaal, FR
    Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency
    BLOOD
    
    H.H. van Boven et al., "Gene-gene and gene-environment interactions determine risk of thrombosis in families with inherited antithrombin deficiency", BLOOD, 94(8), 1999, pp. 2590-2594
68. de Visser, MCH; Rosendaal, FR; Bertina, RM
    A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis
    BLOOD
    
    M.C.H. de Visser et al., "A reduced sensitivity for activated protein C in the absence of factor V Leiden increases the risk of venous thrombosis", BLOOD, 93(4), 1999, pp. 1271-1276
69. Rosendaal, FR; Siscovick, DS
    Factor V Leiden is not a risk factor for myocardial infarction among youngwoman - Response
    BLOOD
    
    F.R. Rosendaal e D.S. Siscovick, "Factor V Leiden is not a risk factor for myocardial infarction among youngwoman - Response", BLOOD, 93(4), 1999, pp. 1433-1433
70. De Groot, CJM; Bloemenkamp, KWM; Duvekot, EJ; Helmerhorst, FM; Bertina, RM; Van der Meer, F; De Ronde, H; Oei, SG; Kanhai, HHH; Rosendaal, FR
    Preeclampsia and genetic risk factors for thrombosis: A case-control study
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    
    C.J.M. De Groot et al., "Preeclampsia and genetic risk factors for thrombosis: A case-control study", AM J OBST G, 181(4), 1999, pp. 975-980
71. Psaty, BM; Koepsell, TD; Lin, DY; Weiss, NS; Siscovick, DS; Rosendaal, FR; Pahor, M; Furberg, CD
    Assessment and control for confounding by indication in observational studies
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
    
    B.M. Psaty et al., "Assessment and control for confounding by indication in observational studies", J AM GER SO, 47(6), 1999, pp. 749-754
72. DENHEIJER M; BROUWER IA; BOS GMJ; BLOM HJ; VANDERPUT NMJ; SPAANS AP; ROSENDAAL FR; THOMAS CMG; HAAK HL; WIJERMANS PW; GERRITS WBJ
    VITAMIN SUPPLEMENTATION REDUCES BLOOD HOMOCYSTEINE LEVELS - A CONTROLLED TRIAL IN PATIENTS WITH VENOUS THROMBOSIS AND HEALTHY-VOLUNTEERS
    Arteriosclerosis, thrombosis, and vascular biology
    
    M. Denheijer et al., "VITAMIN SUPPLEMENTATION REDUCES BLOOD HOMOCYSTEINE LEVELS - A CONTROLLED TRIAL IN PATIENTS WITH VENOUS THROMBOSIS AND HEALTHY-VOLUNTEERS", Arteriosclerosis, thrombosis, and vascular biology, 18(3), 1998, pp. 356-361
73. BRATTSTROM L; LANDGREN F; ISRAELSSON B; LINDGREN A; HULTBERG B; ANDERSSON A; CUSKELLY G; MCNULTY H; STRAIN SS; MCPARTLIN J; WEIR DG; SCOTT JM; DENHEIJER M; BROUWER IA; BLOM HJ; BOS GMJ; SPAANS A; ROSENDAAL FR; THOMAS CMG; HAAK HL; WIJERMANS PW; GERRITS WBJ; NAURATH HJ; JOOSTEN E; RIEZLER R; STABLER SP; ALLEN RH; LINDENBAUM J; PIETRZIK K; PRINZLANGENOHL R; DIERKES J; SALTZMAN E; MASON JB; JACQUES P; SELHUB J; SALEM D; SCHAEFER E; ROSENBERG IH; UBBINK J; VANDERMERE A; VERMACK WJH; DELPORT R; BECKER PJ; POTGIETER HC; WOODSIDE JV; YARNELL JWG; MCMASTER D; YOUNG IS; MCCRUM EE; PATTERSON SS; GEY KF; EVANS AE; CLARKE R; APPLEBY P; HARDING P; SHERLIKER P; COLLINS R; FROST C; LEROY V
    LOWERING BLOOD HOMOCYSTEINE WITH FOLIC-ACID BASED SUPPLEMENTS - METAANALYSIS OF RANDOMIZED TRIALS
    BMJ. British medical journal
    
    L. Brattstrom et al., "LOWERING BLOOD HOMOCYSTEINE WITH FOLIC-ACID BASED SUPPLEMENTS - METAANALYSIS OF RANDOMIZED TRIALS", BMJ. British medical journal, 316(7135), 1998, pp. 894-898
74. DOGGEN CJM; KUNZ G; ROSENDAAL FR; LANE DA; VOS HL; STUBBS PJ; CATS VM; IRELAND H
    A MUTATION IN THE THROMBOMODULIN GENE, (127)G TO A CODING FOR ALA25THR, AND THE RISK OF MYOCARDIAL-INFARCTION IN MEN
    Thrombosis and haemostasis
    
    C.J.M. Doggen et al., "A MUTATION IN THE THROMBOMODULIN GENE, (127)G TO A CODING FOR ALA25THR, AND THE RISK OF MYOCARDIAL-INFARCTION IN MEN", Thrombosis and haemostasis, 80(5), 1998, pp. 743-748
75. BLOEMENKAMP KWM; ROSENDAAL FR; HELMERHORST FM; KOSTER T; BERTINA RM; VANDENBROUCKE JP
    HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO DEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES
    Thrombosis and haemostasis
    
    K.W.M. Bloemenkamp et al., "HEMOSTATIC EFFECTS OF ORAL-CONTRACEPTIVES IN WOMEN WHO DEVELOPED DEEP-VEIN THROMBOSIS WHILE USING ORAL-CONTRACEPTIVES", Thrombosis and haemostasis, 80(3), 1998, pp. 382-387
76. DOGGEN CJM; CATS VM; BERTINA RM; REITSMA PH; VANDENBROUCKE JP; ROSENDAAL FR
    A GENETIC PROPENSITY TO HIGH FACTOR-VII IS NOT ASSOCIATED WITH THE RISK OF MYOCARDIAL-INFARCTION IN MEN
    Thrombosis and haemostasis
    
    C.J.M. Doggen et al., "A GENETIC PROPENSITY TO HIGH FACTOR-VII IS NOT ASSOCIATED WITH THE RISK OF MYOCARDIAL-INFARCTION IN MEN", Thrombosis and haemostasis, 80(2), 1998, pp. 281-285
77. CUSHMAN M; ROSENDAAL FR; PSATY BM; COOK EF; VALLIERE J; KULLER LH; TRACY RP
    FACTOR-V-LEIDEN IS NOT A RISK FACTOR FOR ARTERIAL VASCULAR-DISEASE INTHE ELDERLY - RESULTS FROM THE CARDIOVASCULAR-HEALTH-STUDY
    Thrombosis and haemostasis
    
    M. Cushman et al., "FACTOR-V-LEIDEN IS NOT A RISK FACTOR FOR ARTERIAL VASCULAR-DISEASE INTHE ELDERLY - RESULTS FROM THE CARDIOVASCULAR-HEALTH-STUDY", Thrombosis and haemostasis, 79(5), 1998, pp. 912-915
78. ROSENDAAL FR; DOGGEN CJM; ZIVELIN A; ARRUDA VR; AIACH M; SISCOVICK DS; HILLARP A; WATZKE HH; BERNARDI F; CUMMING AM; PRESTON FE; REITSMA PH
    GEOGRAPHIC-DISTRIBUTION OF THE 20210-G TO 20210-A PROTHROMBIN VARIANT
    Thrombosis and haemostasis
    
    F.R. Rosendaal et al., "GEOGRAPHIC-DISTRIBUTION OF THE 20210-G TO 20210-A PROTHROMBIN VARIANT", Thrombosis and haemostasis, 79(4), 1998, pp. 706-708
79. KLUIJTMANS LAJ; DENHEIJER M; REITSMA PH; HEIL SG; BLOM HJ; ROSENDAAL FR
    THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE AND FACTOR-V-LEIDEN IN THE RISK OF DEEP-VEIN THROMBOSIS
    Thrombosis and haemostasis
    
    L.A.J. Kluijtmans et al., "THERMOLABILE METHYLENETETRAHYDROFOLATE REDUCTASE AND FACTOR-V-LEIDEN IN THE RISK OF DEEP-VEIN THROMBOSIS", Thrombosis and haemostasis, 79(2), 1998, pp. 254-258
80. KAMPHUISEN PW; HOUWINGDUISTERMAAT JJ; VANHOUWELINGEN HC; EIKENBOOM JCJ; BERTINA RM; ROSENDAAL FR
    FAMILIAL CLUSTERING OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR LEVELS
    Thrombosis and haemostasis
    
    P.W. Kamphuisen et al., "FAMILIAL CLUSTERING OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR LEVELS", Thrombosis and haemostasis, 79(2), 1998, pp. 323-327
81. ROSENDAAL FR; VOS HL; POORT SL; BERTINA RM
    PROTHROMBIN 20210A VARIANT AND AGE AT THROMBOSIS
    Thrombosis and haemostasis
    
    F.R. Rosendaal et al., "PROTHROMBIN 20210A VARIANT AND AGE AT THROMBOSIS", Thrombosis and haemostasis, 79(2), 1998, pp. 444-444
82. den Heijer, M; Rosendaal, FR; Blom, HJ; Gerrits, WBJ; Bos, GMJ
    Hyperhomocysteinemia and venous thrombosis: A meta-analysis
    THROMBOSIS AND HAEMOSTASIS
    
    M. den Heijer et al., "Hyperhomocysteinemia and venous thrombosis: A meta-analysis", THROMB HAEM, 80(6), 1998, pp. 874-877
83. TRIEMSTRA AHM; VANDERPLOEG HM; SMIT C; BRIET E; ADER HJ; ROSENDAAL FR
    WELL-BEING OF HEMOPHILIA PATIENTS - A MODEL FOR DIRECT AND INDIRECT EFFECTS OF MEDICAL PARAMETERS ON THE PHYSICAL AND PSYCHOSOCIAL FUNCTIONING
    Social science & medicine (1982)
    
    A.H.M. Triemstra et al., "WELL-BEING OF HEMOPHILIA PATIENTS - A MODEL FOR DIRECT AND INDIRECT EFFECTS OF MEDICAL PARAMETERS ON THE PHYSICAL AND PSYCHOSOCIAL FUNCTIONING", Social science & medicine (1982), 47(5), 1998, pp. 581-593
84. HELMERHORST FM; ROSENDAAL FR; VANDENBROUCKE JP
    THE PILL AND VENOUS THROMBOEMBOLISM - A DISARRAY OF SEVERAL LAYERS OFDEBATE
    Human reproduction
    
    F.M. Helmerhorst et al., "THE PILL AND VENOUS THROMBOEMBOLISM - A DISARRAY OF SEVERAL LAYERS OFDEBATE", Human reproduction, 13(5), 1998, pp. 1119-1120
85. HELMERHORST FM; ROSENDAAL FR; VANDENBROUCKE JP
    VENOUS THROMBOEMBOLISM AND THE PILL - THE WHO TECHNICAL REPORT ON CARDIOVASCULAR-DISEASE AND STEROID-HORMONE CONTRACEPTION - STATE-OF-THE-ART
    Human reproduction (Oxford. Print)
    
    F.M. Helmerhorst et al., "VENOUS THROMBOEMBOLISM AND THE PILL - THE WHO TECHNICAL REPORT ON CARDIOVASCULAR-DISEASE AND STEROID-HORMONE CONTRACEPTION - STATE-OF-THE-ART", Human reproduction (Oxford. Print), 13(11), 1998, pp. 2981-2983
86. LONGSTRETH WT; ROSENDAAL FR; SISCOVICK DS; VOS HL; SCHWARTZ SM; PSATY BM; RAGHUNATHAN TE; KOEPSELL TD; REITSMA PH
    RISK OF STROKE IN YOUNG-WOMEN AND 2 PROTHROMBOTIC MUTATIONS - FACTOR-V-LEIDEN AND PROTHROMBIN GENE VARIANT (G20210A)
    Stroke
    
    W.T. Longstreth et al., "RISK OF STROKE IN YOUNG-WOMEN AND 2 PROTHROMBOTIC MUTATIONS - FACTOR-V-LEIDEN AND PROTHROMBIN GENE VARIANT (G20210A)", Stroke, 29(3), 1998, pp. 577-580
87. BERTINA RM; ROSENDAAL FR
    VENOUS THROMBOSIS - THE INTERACTION OF GENES AND ENVIRONMENT
    The New England journal of medicine
    
    R.M. Bertina e F.R. Rosendaal, "VENOUS THROMBOSIS - THE INTERACTION OF GENES AND ENVIRONMENT", The New England journal of medicine, 338(25), 1998, pp. 1840-1841
88. HILLE ETM; VANDUIJN E; GRUIS NA; ROSENDAAL FR; BERGMAN W; VANDENBROUCKE JP
    EXCESS CANCER MORTALITY IN 6 DUTCH PEDIGREES WITH THE FAMILIAL ATYPICAL MULTIPLE MOLE-MELANOMA SYNDROME FROM 1830 TO 1994
    Journal of investigative dermatology
    
    E.T.M. Hille et al., "EXCESS CANCER MORTALITY IN 6 DUTCH PEDIGREES WITH THE FAMILIAL ATYPICAL MULTIPLE MOLE-MELANOMA SYNDROME FROM 1830 TO 1994", Journal of investigative dermatology, 110(5), 1998, pp. 788-792
89. DOGGEN CJM; CATS VM; BERTINA RM; ROSENDAAL FR
    INTERACTION OF COAGULATION DEFECTS AND CARDIOVASCULAR RISK-FACTORS - INCREASED RISK OF MYOCARDIAL-INFARCTION ASSOCIATED WITH FACTOR-V-LEIDEN OR PROTHROMBIN 20210A
    Circulation
    
    C.J.M. Doggen et al., "INTERACTION OF COAGULATION DEFECTS AND CARDIOVASCULAR RISK-FACTORS - INCREASED RISK OF MYOCARDIAL-INFARCTION ASSOCIATED WITH FACTOR-V-LEIDEN OR PROTHROMBIN 20210A", Circulation, 97(11), 1998, pp. 1037-1041
90. DEVISSER MCH; ROSENDAAL FR; BERTINA RM
    ACTIVATED PROTEIN-C RESISTANCE NOT ASSOCIATED WITH FACTOR-V-LEIDEN ISA RISK FACTOR FOR VENOUS THROMBOSIS
    British Journal of Haematology
    
    M.C.H. Devisser et al., "ACTIVATED PROTEIN-C RESISTANCE NOT ASSOCIATED WITH FACTOR-V-LEIDEN ISA RISK FACTOR FOR VENOUS THROMBOSIS", British Journal of Haematology, 102(1), 1998, pp. 146-146
91. TORN M; ROSENDAAL FR
    THE RISK OF COMPLICATIONS DURING MEDICAL AND SURGICAL INTERVENTIONS IN PATIENTS RECEIVING ORAL ANTICOAGULANT-THERAPY
    British Journal of Haematology
    
    M. Torn e F.R. Rosendaal, "THE RISK OF COMPLICATIONS DURING MEDICAL AND SURGICAL INTERVENTIONS IN PATIENTS RECEIVING ORAL ANTICOAGULANT-THERAPY", British Journal of Haematology, 102(1), 1998, pp. 265-265
92. VANDENBROUCKE JP; HELMERHORST FM; ROSENDAAL FR
    EPIDEMIOLOGY OF ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE
    Annals of internal medicine
    
    J.P. Vandenbroucke et al., "EPIDEMIOLOGY OF ORAL-CONTRACEPTIVES AND CARDIOVASCULAR-DISEASE", Annals of internal medicine, 129(9), 1998, pp. 747-747
93. VANDENBROUCKE JP; ROSENDAAL FR; HELMERHORST FM
    SCIENTIFIC PROBLEMS WITH A NONCAUSAL ARTIFACT - REPLY
    American journal of obstetrics and gynecology
    
    J.P. Vandenbroucke et al., "SCIENTIFIC PROBLEMS WITH A NONCAUSAL ARTIFACT - REPLY", American journal of obstetrics and gynecology, 178(5), 1998, pp. 1106-1107
94. BOSWERGER MGC; FIJNVANDRAAT K; VANVELDHUIZEN AMH; ROSENDAAL FR; PETERS M
    EMOTIONAL ADJUSTMENT OF CHILDREN AND ADOLESCENTS WITH HEMOPHILIA IN RELATION TO THE HIV THREAT
    Haemophilia
    
    M.G.C. Boswerger et al., "EMOTIONAL ADJUSTMENT OF CHILDREN AND ADOLESCENTS WITH HEMOPHILIA IN RELATION TO THE HIV THREAT", Haemophilia, 3(1), 1997, pp. 39-45
95. MAKRIS M; ROSENDAAL FR; PRESTON FE
    FAMILIAL THROMBOPHILIA - GENETIC RISK-FACTORS AND MANAGEMENT
    Journal of internal medicine
    
    M. Makris et al., "FAMILIAL THROMBOPHILIA - GENETIC RISK-FACTORS AND MANAGEMENT", Journal of internal medicine, 242, 1997, pp. 9-15
96. FRANKE CL; KOEHLER PJJ; GORTER JW; KAPPELLE LJ; RINKEL GJE; TJEERDSMA HC; VANGIJN J; DAMMERS JWHH; STRAATMAN HJS; TENHOUTEN R; VEERING MM; BAKKER SLM; DIPPEL D; KOUDSTAAL PJ; VANGEMERT HMA; VANSWIETEN JC; HORN J; KWA IH; LIMBURG M; STAM J; BOON AM; LIEUWENS WHG; VISSCHER F; BOUWSMA C; RUTGERS AWF; SNOEK JW; BROUWERS PJAM; NIHOM J; SOLLEVELD H; CARBAAT PAT; HERTZBERGER LI; KLEIJWEG RP; NANNINGAVANDENNESTE VMH; VANDIEPEN AJH; LINSSEN WHJP; VANNESTE JAL; VOS J; WEINSTEIN HC; SCHIPPER JP; VANDERMEER WK; BERNTSEN PJIM; DEVRIESLEENDERS EM; GEERVLIET JP; TANS RJJ; FEIKEMA WJ; LOHMANN HJHM; VANKASTEEL V; JONGEBLOED FA; LEYTEN QH; VANWENSEN PJM; JANSEN C; SMITS MG; DRIESEN JJM; VANOUDENAARDEN WF; VERHEY JCB; BOTTGER HRF; DRIESSENKLETTER MF; ZWOLS F; VANDERGAAST JB; WITTEBOL MC; LODDER J; VANOOSTENBRUGGE RJ; BEINTEMA KD; HILBERS J; VANDERWEIL HL; VANLIESHOUT HBM; WESTSTRATE W; BERNSEN PLJA; FRENKEN CWGM; POELS EFJ; LINDEBOOM SF; VANDERSTEEN A; GLIMMERVEEN WF; MARTENS EIF; BULENS C; DEVRIESBOS LHP; VENABLES GS; KOSTER JG; SINNIGE LGF; KLAVER MM; KOETSVELDBAART JC; MAUSER HW; DON JA; VANGEUSAU RBA; DIJKMAN MH; HOPPENBROUWERS WJJF; BANFORD WJJF; BRIET PE; EEKHOF JLA; WITJES R; HAMBURGER HL; VANDERSANDE JJ; BATH P; HANKEY GJ; KONING E; RICCI S; BERENDES JN; HOOFF LJMA; VANSPREEKEN ACGA; WOUTERS HNA; KUHLER AR; MALLO GN; VANWALBEEK HK; GAUW JC; VERMEIJ AJ; VERHEIJ JCB; SWEN JWA; CANHAO P; KEYSER A; HOLSCHER RS; DEJONG GJ; KRAAIER V; AGRA A; BRIETE; DEVRIESGOLDSCHEMDINGI J; EIKELBOOM BC; GREEBE P; HAUER RNW; HERMSEN MG; LOELIGER EA; POP GAM; ROSENDAAL FR; SCHOBBEN AFAM; SIMOONS ML; SIXMA FF; SLABBERS DCV; TIJSSEN JCP; VANCREVAL H; VANES GA; VERHEUGT FWA; VERMEULIN M; WEVER EFD; WULFSEN EKM
    A RANDOMIZED TRIAL OF ANTICOAGULANTS VERSUS ASPIRIN AFTER CEREBRAL-ISCHEMIA OF PRESUMED ARTERIAL ORIGIN
    Annals of neurology
    
    C.L. Franke et al., "A RANDOMIZED TRIAL OF ANTICOAGULANTS VERSUS ASPIRIN AFTER CEREBRAL-ISCHEMIA OF PRESUMED ARTERIAL ORIGIN", Annals of neurology, 42(6), 1997, pp. 857-865
97. ROSENDAAL FR
    THROMBOSIS IN THE YOUNG - EPIDEMIOLOGY AND RISK-FACTORS - A FOCUS ON VENOUS THROMBOSIS
    Thrombosis and haemostasis
    
    F.R. Rosendaal, "THROMBOSIS IN THE YOUNG - EPIDEMIOLOGY AND RISK-FACTORS - A FOCUS ON VENOUS THROMBOSIS", Thrombosis and haemostasis, 78(1), 1997, pp. 1-6
98. SISCOVICK DS; SCHWARTZ SM; ROSENDAAL FR; PSATY BM
    THROMBOSIS IN THE YOUNG - EFFECT OF ATHEROSCLEROTIC RISK-FACTORS ON THE RISK OF MYOCARDIAL-INFARCTION ASSOCIATED WITH PROTHROMBOTIC FACTORS
    Thrombosis and haemostasis
    
    D.S. Siscovick et al., "THROMBOSIS IN THE YOUNG - EFFECT OF ATHEROSCLEROTIC RISK-FACTORS ON THE RISK OF MYOCARDIAL-INFARCTION ASSOCIATED WITH PROTHROMBOTIC FACTORS", Thrombosis and haemostasis, 78(1), 1997, pp. 7-12
99. HELMERHORST FM; BLOEMENKAMP KWM; ROSENDAAL FR; VANDENBROUCKE JP
    ORAL-CONTRACEPTIVES AND THROMBOTIC DISEASE - RISK OF VENOUS THROMBOEMBOLISM
    Thrombosis and haemostasis
    
    F.M. Helmerhorst et al., "ORAL-CONTRACEPTIVES AND THROMBOTIC DISEASE - RISK OF VENOUS THROMBOEMBOLISM", Thrombosis and haemostasis, 78(1), 1997, pp. 327-333
100. VANDERMEER FJM; KOSTER T; VANDENBROUCKE JP; BRIET E; ROSENDAAL FR
     THE LEIDEN THROMBOPHILIA STUDY (LETS)
     Thrombosis and haemostasis
     
     F.J.M. Vandermeer et al., "THE LEIDEN THROMBOPHILIA STUDY (LETS)", Thrombosis and haemostasis, 78(1), 1997, pp. 631-635